Evidence map›Paper›PMID 25611513›Full record

ArticleNeuron2015

Diversity of transgenic mouse models for selective targeting of midbrain dopamine neurons.

Stephan Lammel, Elizabeth E Steinberg, Csaba Földy, Nicholas R Wall, Kevin Beier, Liqun Luo, Robert C Malenka

Open access · bronzeAbstract read
In one paragraph

Article in Neuron, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 208 papers.

0numbers the graph read from it
0cells of the map it votes in
208citing papers in PubMed
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

208 citing papers in PubMed, 373 citations in OpenAlex.

  1. Activation of mu-opioid receptors slows pacemaking in hypothalamic A11 dopamine neurons.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Synaptogyrin-3 plays a critical role in addiction-related dopamine dysfunction and behavioral maladaptations.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. 5-HTMolecular psychiatry · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Salience Signaling and Stimulus Scaling of Ventral Tegmental Area Glutamate Neuron Subtypes.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  18. Article
  19. Article
  20. Article

148 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Stephan LammelNancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 265 Campus Drive, Stanford CA 94305-5453, USA. Electronic address: lammel@berkeley.edu.
Elizabeth E SteinbergNancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 265 Campus Drive, Stanford CA 94305-5453, USA.
Csaba FöldyNancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 265 Campus Drive, Stanford CA 94305-5453, USA; Department of Molecular and Cellular Physiology, Stanford University School of Medicine, 265 Campus Drive, Stanford CA 94305-5453, USA.
Nicholas R WallNancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 265 Campus Drive, Stanford CA 94305-5453, USA.
Kevin BeierNancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 265 Campus Drive, Stanford CA 94305-5453, USA; Howard Hughes Medical Institute and Department of Biology, Stanford University, Stanford, CA 94305, USA.
Liqun LuoHoward Hughes Medical Institute and Department of Biology, Stanford University, Stanford, CA 94305, USA.
Robert C MalenkaNancy Pritzker Laboratory, Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, 265 Campus Drive, Stanford CA 94305-5453, USA. Electronic address: malenka@stanford.edu.
Stanford University · USHoward Hughes Medical Institute · USStanford Medicine · US

Funding

TRANSGENIC COREP01DA008227 · NIDA · YALE UNIVERSITY · PI NESTLER, ERIC J. · 1993 to 2018
$28.1M
CLARITY: fully-assembled biologyR01MH099647 · NIMH · STANFORD UNIVERSITY · PI DEISSEROTH, KARL A. · 2012 to 2016
$23.0M
VECTOR COREP30NS069375 · NINDS · STANFORD UNIVERSITY · PI STEINBERG, GARY K · 2011 to 2019
$6.3M
Circuit Control By EndocannabinoidsK99DA034029 · NIDA · STANFORD UNIVERSITY · PI FOLDY, CSABA · 2012 to 2013
$275k
Elucidating input-output relations of rewarding and aversive VTA dopamine neuronsF32DA038913 · NIDA · STANFORD UNIVERSITY · PI BEIER, KEVIN T · 2015 to 2015
$54k
Howard Hughes Medical InstituteNIDA NIH HHS DA008227NIDA NIH HHS F32 DA038913NIDA NIH HHS K99 DA034029NIDA NIH HHS K99DA034029NIDA NIH HHS P01 DA008227NIMH NIH HHS R01 MH099647NIMH NIH HHS TR01-MH099647NINDS NIH HHS NIH NS069375NINDS NIH HHS P30 NS069375
6 · The paper itself

Abstract

Ventral tegmental area (VTA) dopamine (DA) neurons have been implicated in reward, aversion, salience, cognition, and several neuropsychiatric disorders. Optogenetic approaches involving transgenic Cre-driver mouse lines provide powerful tools for dissecting DA-specific functions. However, the emerging complexity of VTA circuits requires Cre-driver mouse lines that restrict transgene expression to a precisely defined cell population. Because of recent work reporting that VTA DA neurons projecting to the lateral habenula release GABA, but not DA, we performed an extensive anatomical, molecular, and functional characterization of prominent DA transgenic mouse driver lines. We find that transgenes under control of the tyrosine hydroxylase, but not the dopamine transporter, promoter exhibit dramatic non-DA cell-specific expression patterns within and around VTA nuclei. Our results demonstrate how Cre expression in unintentionally targeted cells in transgenic mouse lines can confound the interpretation of supposedly cell-type-specific experiments. This Matters Arising paper is in response to Stamatakis et al. (2013), published in Neuron. See also the Matters Arising Response paper by Stuber et al. (2015), published concurrently with this Matters Arising in Neuron.

Indexed as

Action PotentialsAnimalsDopamineDopamine Plasma Membrane Transport ProteinsDopaminergic NeuronsGABAergic Neuronsgamma-Aminobutyric AcidGene ExpressionHabenulaMesencephalonMiceMice, TransgenicModels, AnimalPromoter Regions, GeneticTranscriptional ActivationVentral Tegmental AreaDopamineDopamine Plasma Membrane Transport Proteinsgamma-Aminobutyric Acid

Identifiers

PMID25611513
PMCPMC5037114
OpenAlexW2109242838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.